Metabolic Investigational

MOTS-c

Also known as: Mitochondrial ORF of the 12S rRNA Type-c, MOTS-c Peptide

A mitochondrial-derived exercise mimetic peptide that activates AMPK, enhances metabolic homeostasis, and improves insulin sensitivity and exercise performance.

Popularity B+
Class Mitochondrial-Derived Peptide
Half-Life Not fully characterized (~4-6 hours estimated)
Form Lyophilized powder
Jump to Dosing ↓
peptides in the gym
Research-Backed User Reports Sourced Updated Mar 2026
// Overview

What is MOTS-c?

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c) is a 16-amino acid peptide encoded within the mitochondrial genome. Discovered in 2015 by Dr. Changhan David Lee at USC, MOTS-c is one of the first known mitochondrial-derived peptides (MDPs) with significant systemic metabolic effects.

MOTS-c functions as a retrograde signaling molecule — the mitochondria communicate with the nuclear genome and other tissues to regulate metabolic homeostasis. In animal studies, MOTS-c has been shown to prevent age-dependent and high-fat-diet-induced insulin resistance, enhance exercise capacity, and improve overall metabolic health.

Often called an “exercise mimetic,” MOTS-c activates the AMPK pathway — the same metabolic switch triggered by physical exercise. This makes it particularly interesting for individuals seeking metabolic benefits of exercise through pharmacological enhancement.

Found this helpful?

Join our newsletter for compound breakdowns, dosing protocols, and research updates.

Free forever. No spam. Unsubscribe anytime.

// How It Works

How MOTS-c Works

MOTS-c is a mitochondrial signaling peptide with broad metabolic effects:

  1. AMPK activation — The primary mechanism. MOTS-c activates AMP-activated protein kinase, the master metabolic regulator that is also activated by exercise, caloric restriction, and metformin.
  2. Folate-methionine cycle regulation — MOTS-c inhibits the folate cycle, which redirects metabolic flux and activates AMPK through changes in purine biosynthesis and cellular energy status.
  3. Nuclear translocation — Under metabolic stress, MOTS-c translocates from mitochondria to the nucleus where it regulates gene expression related to antioxidant defense and metabolic adaptation.
  4. Insulin sensitization — Improves skeletal muscle glucose uptake independent of insulin, similar to exercise-induced GLUT4 translocation.
// Dosage Protocols

Dosage Information (User-Reported)

Disclaimer: Dosage information is compiled from user reports and published research. This is not medical advice. Consult a healthcare professional before use.
Level Dose Frequency Duration
Standard 5 mg 3x per week (M/W/F) 4-8 weeks
Advanced 10 mg 3x per week 4-8 weeks
Loading 10 mg Daily for 5 days, then 3x/week 8 weeks

What to Expect

Week 1-2

Subtle increase in energy and exercise tolerance. Some users report improved endurance during cardio within the first week.

Week 3-4

More noticeable metabolic effects. Improved fasting glucose readings. Enhanced workout performance and reduced post-exercise fatigue.

Week 5-8

Body composition changes become apparent. Reduced visceral fat, improved metabolic markers. Exercise capacity significantly enhanced.

Month 2-3

Cumulative metabolic benefits. Users report feeling metabolically younger with sustained energy throughout the day.

Common Stacks

NAD+

Mitochondrial Synergy

Both target mitochondrial function — MOTS-c + NAD+ precursors enhance cellular energy production

BPC-157

Recovery Stack

Combines metabolic enhancement with tissue repair for comprehensive recovery

AOD-9604

Fat Loss Amplification

AMPK activation from MOTS-c pairs with GH-fragment-driven lipolysis

// Preparation

Reconstitution & Storage

Reconstitute with bacteriostatic water. For a 5mg vial, add 2mL for 2.5mg/mL concentration. Do not shake — swirl gently. Refrigerate after reconstitution.

Storage: Lyophilized: -20°C for long-term, 2-8°C short-term. Reconstituted: 2-8°C, use within 14 days.
// Safety Profile

Side Effects & Safety

Potential Side Effects

  • ! Injection site redness or irritation
  • ! Mild headache
  • ! Transient fatigue (first few doses as metabolism adjusts)
  • ! Minor GI discomfort
  • ! Generally very well-tolerated with minimal reported side effects

Contraindications

  • ⚠ Pregnancy or breastfeeding
  • ⚠ Active cancer (AMPK activation effects on tumor metabolism not fully understood)
  • ⚠ Severe metabolic disorders without physician supervision

Legal & Regulatory Status

Not FDA-approved. Investigational research peptide. Available from peptide vendors for research purposes. Not a controlled substance.

// Research

Published Research

// Related Compounds

Other Metabolic Guides

Subcutaneous injection technique pinching abdominal skin fold for peptide admini

Cagrilintide

A long-acting amylin analog that amplifies weight loss when paired with semaglutide — the amylin component of CagriSema's…

Read Guide →
Lyophilized BPC157 powder as a white cake inside a sealed vial

BPC-157 Arginate (Oral)

The oral form of BPC-157 — gastric-acid stable and designed for direct GI tract healing. No injections needed…

Read Guide →
TB500 thymosin beta4 peptide vial used for recovery and healing research

TB-500 Fragment

A concentrated fragment of Thymosin Beta-4 focused on the core actin-binding domain — smaller molecule, targeted tissue repair.

Read Guide →

Stay informed on MOTS-c.

New research, dosage updates, and protocol breakdowns. Straight to your inbox.

Free forever. No spam. Unsubscribe anytime.

This content is for informational and educational purposes only. MOTS-c is sold for research purposes. Never Natty does not condone or encourage the use of any substance in violation of any laws. Consult a healthcare professional before using any compound discussed on this site.